Characterization of HSV Derived AAV9 Vectors

被引：0

作者：

Pechan, Peter ^{[1
]}

Golebiowski, Diane ^{[1
]}

Seregin, Alexey ^{[1
]}

Zapata, Nicole ^{[1
]}

Levi, Elise ^{[2
]}

Kitsos, Christine ^{[2
]}

Lu, Robert ^{[2
]}

Amorrortu, Alvaro ^{[3
]}

Morris, Carl ^{[1
]}

机构：

[1] Solid Biosci, Dev, Cambridge, MA USA

[2] Solid Biosci, PD, Cambridge, MA USA

[3] Solid Biosci, Operat, Cambridge, MA USA

来源：

MOLECULAR THERAPY | 2019年 / 27卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

737

引用

页码：347 / 347

页数：1

共 50 条

[21] Preventing PrPC Synthesis in Mice with Adeno-Associated Viral Vectors AAV2, AAV6 and AAV9
DeArmond, Stephen
Ahn, Misol
Bajsarowicz, Krystyna
Oehler, Abby
Bankiewicz, Krystof
[J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (06): : 555 - 555
[22] AAV9: Over the Fence and Into the Woods ...
Forsayeth, John R.
Bankiewicz, Krystof S.
[J]. MOLECULAR THERAPY, 2011, 19 (06) : 1006 - 1007
[23] Endothelial retargeting of AAV9 in vivo
Bozoglu, T.
Lee, S.
Ziegler, T.
Kupatt, C.
[J]. EUROPEAN HEART JOURNAL, 2022, 43 : 3090 - 3090
[24] Improved heart specific gene transfer of AAV9 vectors with microRNA regulated transgene expression
Geisler, Anja
Jungmann, Andreas
Vetter, Roland
Muller, Oliver
Fechner, Henry
[J]. HUMAN GENE THERAPY, 2009, 20 (11) : 1381 - 1381
[25] Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease
Doerfler, Phillip A.
Todd, Adrian G.
Clement, Nathalie
Falk, Darin J.
Nayak, Sushrusha
Herzog, Roland W.
Byrne, Barry J.
[J]. HUMAN GENE THERAPY, 2016, 27 (01) : 43 - 59
[26] Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
Inagaki, Katsuya
Fuess, Sally
Storm, Theresa A.
Gibson, Gregory A.
Mctiernan, Charles F.
Kay, Mark A.
Nakai, Hiroyuki
[J]. MOLECULAR THERAPY, 2006, 14 (01) : 45 - +
[27] Regenxbio gets $40 million for AAV9
Cross, Ryan
[J]. CHEMICAL & ENGINEERING NEWS, 2018, 96 (45) : 15 - 15
[28] Identification and validation of target receptors for AAV9
Roach, M.
Webster, C.
Azzouz, M.
[J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A56 - A56
[29] A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors
Davis-Gardner, Meredith E.
Weber, Jesse A.
Xie, Jun
Pekrun, Katja
Alexander, Eric A.
Weisgrau, Kim L.
Furlott, Jessica R.
Rakasz, Eva G.
Kay, Mark A.
Gao, Guangping
Farzan, Michael
Gardner, Matthew R.
[J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
[30] Recombinant AAV9 vectors to silence the mutant SOD1 gene in Amyotrophic Lateral Sclerosis
Biferi, M. G.
Cohen-Tannoudji, M.
Roda, M.
Barkats, M.
[J]. HUMAN GENE THERAPY, 2013, 24 (12) : A117 - A117

← 1 2 3 4 5 →